SKI Market

Indian Indices

Nifty

24,008.00 -265.80
(-1.10%)

Sensex

79,454.47 -880.34
( -1.10%)

Bank Nifty

53,595.25 -770.40
( -1.42%)

Nifty IT

35,880.10 -122.35
( -0.34%)

Global Indices

Nasdaq

41,380.81 245.84
(0.60%)

Dow Jones

5,684.33 32.05
(0.57%)

Hang Seng

37,492.25 563.62
(1.53%)

Nikkei 225

8,531.61 -27.72
(-0.32%)

Forex

USD-INR

84.70 0.29
(0.35%)

EUR-INR

96.08 0.41
(0.42%)

GBP-INR

112.96 0.38
(0.34%)

JPY-INR

0.59 0.00
(0.19%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

360.7264827

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

25.8

120075.94

EPS(TTM)

Face Value()

Div & Yield %

57.63

0.87

Back

Ridhi Synthetics standalone net profit declines 7.50% in the September 2024 quarter

Nov 14,2024

Net profit of Ridhi Synthetics declined 7.50% to Rs 0.37 crore in the quarter ended September 2024 as against Rs 0.40 crore during the previous quarter ended September 2023. Sales remain constant at Rs 0.11 crore in the quarter ended September 2024 and also during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	0.11	0.11	0
OPM %	-27.27	18.18	-
PBDT	0.50	0.51	-2
PBT	0.49	0.51	-4
NP	0.37	0.40	-8

24,008.00 -265.80 (-1.10%)

79,454.47 -880.34 ( -1.10%)

53,595.25 -770.40 ( -1.42%)

35,880.10 -122.35 ( -0.34%)

41,380.81 245.84 (0.60%)

5,684.33 32.05 (0.57%)

37,492.25 563.62 (1.53%)

8,531.61 -27.72 (-0.32%)

84.70 0.29 (0.35%)

96.08 0.41 (0.42%)

112.96 0.38 (0.34%)

0.59 0.00 (0.19%)